Seres Therapeutics, Inc. (NASDAQ: MCRB ) develops microbiome-based therapeutics to treat conditions caused by imbalances in the human gut flora. Since my January article, the company has made important strides, such as the anticipated sale of VOWST to Nestlé HealthMy name is Myriam Hernandez Alvarez. I received the Electronics and Telecommunication Engineering degree from the Escuela Politecnica Nacional, Quito, Ecuador, the M.Sc. degree in computer science from Ohio University, Athens, OH, USA, a graduate ...